Piramal Pharma Limited has announced a board meeting to be held on Wednesday, November 5, 2025, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025. The company also announced the continuation of a trading window closure for dealing in the company’s securities, which commenced on October 1, 2025, and will remain closed until November 7, 2025.
Board Meeting Announcement
Piramal Pharma Limited will convene a meeting of its Board of Directors on Wednesday, November 5, 2025. During this meeting, the board will review and approve the unaudited financial results of the company. This includes both standalone and consolidated results for the quarter and half year which concluded on September 30, 2025.
Trading Window Closure
In addition to the financial results, Piramal Pharma Limited has announced that the trading window for dealing in the company’s securities, which has been closed since Wednesday, October 1, 2025, will remain closed until Friday, November 7, 2025. This period includes both days.
Source: BSE
